Wai Hong Wilson Tang, MD

Appointed
2004

Education & Fellowships

Fellowship - Cleveland Clinic
Advanced heart failure/transplant
Cleveland, OH
2004

Fellowship - Cleveland Clinic
Cardiology, Heart Failure Transplantation
Cleveland, OH
2004

Fellowship - Cleveland Clinic
Cardiology
Cleveland, OH
2003

Fellowship - Cleveland Clinic
Cardiovascular Medicine
Cleveland, OH
2003

Fellowship - Stanford University School of Medicine
Postdoctoral research fellowship
Stanford, CA
2000

Fellowship - Stanford University School of Medicine
Cardiovascular Medicine
Stanford, CA
2000

Residency - Stanford University Medical Center
Internal Medicine
Palo Alto, CA
1999

Residency - Stanford University Medical Center
Stanford, CA
1999

Residency - Stanford University Medical Center
Internal Medicine
Stanford, CA
1999

Internship - Stanford University Medical Center
Internal Medicine
Palo Alto, CA
1997

Medical Education - Harvard Medical School
Boston, MA
1996

Undergraduate - Brown University
Natural Sciences
Providence, RI
1992

Professional Highlights

• Research Director, Section of Heart Failure and Cardiac Transplantation Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at the Cleveland Clinic
• Director, NIH Clinical and Translational Sciences Collaborative Hub Research Capacity, Cleveland Clinical and Translational Sciences Collaborative
• Medical Director, Center for Cardiovascular Diagnostics and Prevention, Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic

Certifications

• Internal Medicine
• Internal Medicine - Cardiovascular Disease
• Internal Medicine - Advanced Heart Failure and Transplant Cardiology

Specialty Interests

Advanced Heart Failure and Transplant Cardiology, Cardiovascular Disease, Cardiomyopathy, Critical Care Cardiology, Mechanical Circulatory Support, Cardiac Transplantation, Inherited Cardiovascular Diseases, Cardiac Sarcoidosis, Cardiac Amyloidosis, Cancer Heart Disease, Cardiorenal Syndrome, Myocardial Biopsy, Invasive Hemodynamics

Awards & Honors

• Fellow, American College of Cardiology, 2005
• Fellow, American Heart Association, 2006
• Elected member, American Society of Clinical Investigation, 2013
• Top Doctors for Cardiovascular Diseases (2012-9) and Cancer (Cardiovascular Disease, 2014-9)
• 2016 Maria and Sam Miller Professional Excellence Award for Scientific Achievement in Clinical Research
• Fellow, Heart Failure Society of America, 2017
• Elected member, Association of American Physicians, 2018

Innovations & Patents

• Research funding from National Institutes of Health

Memberships

• American College of Cardiology
• American Heart Association
• Heart Failure Society of America
• International Society of Heart and Lung Transplantation
• American Society of Clinical Investigations
• International Society of Cardiomyopathies, Myocarditis, and Heart Failure

See publications for Wai Hong Wilson Tang, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/26/2025, Dr. Tang has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Tang receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Alexion Pharmaceuticals, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.